| |
pCR/mRCB
|
pCR
|
---|
| |
No
|
Yes
|
No
|
Yes
|
---|
Clinical Response to AC
|
complete response
|
5
|
18
|
8
|
15
|
partial response
|
36
|
31
|
39
|
28
|
stable disease
|
20
|
2
|
20
|
2
|
progressive disease
|
2
|
0
|
2
|
0
|
- Clinical response to neoadjuvant AC (doxorubicin/cyclophosphamide) and pCR)/minimal RCB after subsequent neoadjuvant ixabepilone or paclitaxel in the GSE41998 TNBC cohort [26]